Search results :

Tolterodine

More information: STITCH, PubChem (stereo-specific compounds: 1, 2) and possibly Wikipedia

ATC Code: G04BD07

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Dry mouth 1.6% - 30.5% 7.7% x x x x x x x x x x x x x x x
Constipation 0.7% - 6.6% 4.3% x x x x x x x x x x x x x x x
Chest pain 3.4% x x x x x x x
Dyspepsia 3.1% 1.4% x x x x x x x x x x x x x x x
Somnolence 3% x x x x x x x x x x x x x x x
Abdominal pain 2.5% 1.6% x x x x x x x x x x x x x x x
Headache 1% - 3.7% 4.5% x x x x x x x x x x x x x x x
Bronchitis 2.1% x
Dysuria 1.6% - 2.5% 0.2% x x x x x x x x x x x x x x x
Dizziness 1.8% 1% x x x x x x x x x x x x x x x
Vertigo 1.8% 1% x x x x x x x x
Dry skin 1.7% x x x x x x x
Flatulence 1.3% x x
Weight increased 1.3% x x x x x x x
Fatigue 1.2% 0.8% x x x x x x x x x x x x x x x
Abnormal vision 0.8% 0.4% x x x x x x x x x x x x x x x
Sinusitis 0.6% 0.6% x x x x x x x x x
Anaphylactic shock postmarketing x x x x
Angioedema postmarketing x x x x x x x x x x x
Confusional state postmarketing x x x x x x x x x
Delusion postmarketing x x x x x x x x x
Diarrhoea postmarketing x x x x x x x x x x x x
Hallucination postmarketing x x x x x x x x x x x x x
Palpitations postmarketing x x x x x x x x x x
Tachycardia postmarketing x x x x x x x x x x x x x x
Oedema peripheral postmarketing x x x x x x x x x x x x x x
Disorientation postmarketing x x x x x x x x x
Memory impairment postmarketing x x x x x x x x x
Anaphylactoid reaction postmarketing x x x x x x x x x x
Dementia postmarketing x x x x x x
Anxiety x x x x x x x
Arthralgia x x x x x x
Infection x x x x x x
Oedema x
Flushing x
Gastrooesophageal reflux disease x
Hypersensitivity x
Pain x
Upper respiratory tract infection x
Urinary tract infection x x
Xerophthalmia x x x x x x x x x x x x x x
Urinary retention x x x x x x x x x x x x x x x
Accommodation disorder x x x x x x
Dry eye x x x x x x x x
Influenza-like symptoms x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TOLTERODINE TARTRATE / DETROL LA

Side effects:15
Source:FDA

tolterodine tartrate tablets / Detrol

Side effects:19
Source:FDA

TOLTERODINE TARTRATE / DETROL LA

Side effects:21
Source:FDA

tolterodine

Side effects:27
Source:FDA Structured Product Label

TOLTERODINE

Side effects:27
Source:FDA Structured Product Label

TOLTERODINE

Side effects:26
Source:FDA Structured Product Label

TOLTERODINE L-TARTRATE / DETROL LA

Side effects:30
Source:Health Canada

TOLTERODINE TARTRATE / DETROL

Side effects:24
Source:FDA

tolterodine tartrate tablets / Detrol

Side effects:25
Source:FDA

TOLTERODINE TARTRATE / DETROL

Side effects:26
Source:FDA

TOLTERODINE

Side effects:32
Source:FDA Structured Product Label

TOLTERODINE

Side effects:32
Source:FDA Structured Product Label

TOLTERODINE TARTRATE / DETROL LA

Side effects:32
Source:FDA

TOLTERODINE L-TARTRATE / DETROL

Side effects:34
Source:Health Canada

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label